INS and type 2 diabetes mellitus: GAS5 levels are markedly lower in serum samples from individuals diagnosed with type 2 diabetes mellitus (T2DM) and it affects insulin signaling and glucose uptake by binding to UPF1 and regulating insulin receptor expression [40].